Groundbreaking approach, Faster progress.
Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio.
Standardize across your entire portfolio
Unlock better ROI with our platform-wide solutions. With features like standardized workflows, single sign-on and IRT Integration, you’ll see increased efficiency and scalability in your trials.
The Medable platform enables 24/7 accessibility and multi-study use that spans across your entire organization.
The power of scale
Build your tools once, them use them again. Medable enables reusability standards so that building and implementing future trials is faster and easier.
Make every moment count
With one complete view of data across your portfolio, you’ll make faster, more informed decisions saving time and making a difference where it matters.
Extensive DCT Network
Do more with your study by leveraging our extensive network of partners ranging from retail pharmacy and site networks, data providers for RWE and LTFU, and direct-to-patient offering of connected sensors and home health providers.
The Tufts Center for the Study of Drug Development: Impact Report
Findings from Tufts CSDD show net financial benefits range from 5x for Phase II and 13x for Phase III trials, equating to roughly $10 million ROI and $39 million ROI, respectively. Download the report to learn more.
The latest from Medable
Podcast: Michelle Longmire and David Fajgenbaum of EveryCure join the PharmaExec podcast
Medable CEO Michelle Longmire and Dr. David Fajgenbaum, co-founder of EveryCure, join Pharmaceutical Executive podcast to talk about their partnership adn navigating the regulatory landscape.
Use case: Implementing digital solutions to improve oncology trial experience & efficiency
A top 10 pharmaceutical company looked to Medable to streamline participant burden and enhance site and team experience in oncology trials, while establishing a scalable template for future trials in oncology and other areas.
What it really takes to adopt eConsent across large pharma
Learn about the benefits of adopting consent management technology and best practices around developing change management and training programs to help sponsors, CROs and sites get the most out of eConsent.